MTL
Asset Logo

Mantle Minerals Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

โ›๏ธ MINING

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

N/A
Annual Growth

5 years average annual growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

8
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Mantle Minerals Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2000-07-11. The Companyโ€™s gold projects include Roberts Hill Tenement, Mt Berghaus Tenement, and The Yule River Project. The Roberts Hill Tenement cover approximately 467 square kilometers of gold tenements, its vast area in the Mallina Hill Basin lies about 5 kilometers (km) northwest from the Hemi, Wingina and Whitnall discoveries. Mt Berghaus Tenements total about 140 square kilometers over the Mallina Basin. The Yule River Project covers about 141 square kilometers of the Scholl Shear Zone, which strikes northeast within the Archean Louden Volcanics. Its Pardoo Nickel Project is a discovery, nestled in 89 square kilometers of shrub and red dirt plains 120 km east of the regional center of Port Hedland. The Companyโ€™s United States-based lithium projects, Colombus Marsh and Rhodes Marsh, are located approximately 50 km and 70 km from the Silver Peak mine.

๐Ÿ“ˆ Performance

Price History

-99.17%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.00

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in MTL

8

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

52 weeks

๐Ÿ’ต Average investment amount

$621

โฐ Last time a customer invested in MTL

6 days
MTL investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

13%

50k - 100k

50%

Less than 50k

38%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
๐Ÿ™‹ Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in MTL also invest in...

iShares S&P 500 ETF

IVV

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

๐Ÿ™Œ Performance (5Yr p.a)

17.81%

๐Ÿ“Š Share price

$63.09 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

3.20%

๐Ÿ“Š Share price

$102.79 AUD

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

๐Ÿ’ธ FINANCIALS

๐Ÿงฑ MATERIALS

โ›ณ๏ธ DIVERSIFIED

Barton Gold Holdings Ltd. operates as a gold exploration company. The company is headquartered in Adelaide, South Australia. The company went IPO on 2021-06-28. The firm has a pipeline of advanced exploration projects and brownfield mines, and 100% ownership of the only regional gold mill in the central Gawler Craton of South Australia. The company has about 5,000 square kilometers tenure in the richly mineralized central Gawler Craton of South Australia. The projects are grouped near the junction of the Perth, Alice Springs / Darwin and Adelaide railways, about 600 kilometers (km) northwest of Adelaide. The company is focused on a series of exploration programs at its Tarcoola, Tunkillia and Challenger projects. The Tarcoola Project is located about 70 km north-northwest of the Tunkillia Project on 1,640 square kilometers of tenements. The Tunkillia Project is located about 70 km south-southeast of the Tarcoola Project on a 1,360 square kilometers tenement package. The Challenger Project is located approximately 730 km northwest of Adelaide, South Australia and 130km NW of the Tarcoola Project.

๐Ÿ“Š Share price

$0.31 AUD

โ›๏ธ MINING

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

๐Ÿ™Œ Performance (5Yr p.a)

22.45%

๐Ÿ“Š Share price

$50.58 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

๐Ÿค– TECHNOLOGY

Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. The company is headquartered in Eveleigh, New South Wales. The company went IPO on 2021-08-25. The firm is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. The company is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. The company has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.

๐Ÿ“Š Share price

$3.50 AUD

๐Ÿ“ฆ LOGISTICS

Want more shares? Try these...

MTLDB

Compare
Add to watchlist